HOSPITALIZATIONS AMONG PATIENTS WITH BOTH COLORECTAL CANCER AND TYPE II DIABETES MELLITUS TREATED WITH METFORMIN VS. SULFONYLUREAS: A SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Rane, A. [1 ]
Reddy, S. [2 ]
Kaliki, S. [2 ]
Kaler, N. [2 ]
Dungrani, R. K. [2 ]
Patel, N. [2 ]
Murimi, I. B. [2 ]
机构：
[1] Agios Pharmaceut, Cambridge, MA USA
[2] MCPHS Univ, Boston, MA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD116
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS ANALYSIS OF METFORMIN COMBINED WITH SAXAGLIPTIN VS. METFORMIN COMBINED WITH SULFONYLUREAS IN TYPE 2 DIABETES PATIENTS IN ARGENTINA
    Elgart, J.
    Caporale, J.
    Gagliardino, J. J.
    Aiello, E. C.
    Waschbusch, M.
    Jotimliansky, L.
    VALUE IN HEALTH, 2010, 13 (03) : A61 - A61
  • [12] Incidence and time course of surgical complications by cancer stage and site among Medicare patients undergoing elective colorectal resection for cancer: An analysis of the SEER-Medicare database
    Johnston, Stephen
    Ammann, Eric
    Nayak, Akhil
    Nagle, Deborah
    Patkar, Anuprita
    Charlton, Mary
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 94 - 95
  • [13] Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis
    Chen, Lu
    Chubak, Jessica
    Boudreau, Denise M.
    Barlow, William E.
    Weiss, Noel S.
    Li, Christopher I.
    CANCER RESEARCH, 2017, 77 (21) : 6033 - 6041
  • [14] Trends in treatment among elderly colorectal cancer patients in the US: Evidence from linked SEER-Medicare data
    Lang, K.
    Lines, L. M.
    Lee, D. W.
    Korn, J. R.
    Vanness, D. J.
    Earle, C.
    Menzin, J.
    VALUE IN HEALTH, 2008, 11 (03) : A9 - A9
  • [15] Effects of Metformin, sulfonylureas, and insulin on weight changes in patients with type II diabetes mellitus - a pilot study
    Sarna, PK
    Moonesinghe, KD
    Cullum-Dugan, D
    Sternthal, E
    Apovian, CM
    OBESITY RESEARCH, 2001, 9 : 158S - 158S
  • [16] SURVIVAL ADVANTAGE OF METFORMIN IN PATIENTS WITH COLORECTAL CANCER AND TYPE II DIABETES MELLITUS: THE MIDDLE EASTERN PERSPECTIVE
    Ali, Shamseddine
    Lana, Hamieh
    Deborah, Mukherji
    Sally, Temraz
    Christopher, Garrett
    ANNALS OF ONCOLOGY, 2014, 25
  • [17] Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer
    Al Omari, Amal
    Abdelkhaleq, Hadeel
    Al-Hussaini, Maysa
    Turfa, Rim
    Awad, Nour
    Hassan, Manal M.
    Alfaqih, Mahmoud A.
    Garrett, Christopher R.
    JOURNAL OF GLOBAL ONCOLOGY, 2018, 4 : 1 - 10
  • [18] A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus
    Bradley, Marie C.
    Ferrara, Assiamira
    Achacoso, Ninah
    Ehrlich, Samantha F.
    Quesenberry, Charles P., Jr.
    Habel, Laurel A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (05) : 525 - 530
  • [19] Palliative care utilization and trends among patients with metastatic breast cancer: A SEER-Medicare analysis.
    Giap, Fantine
    Hong, Young-Rock
    Xie, Zhigang
    Li, Yujia
    Guo, Yi
    Bradley, Julie Ann
    Oladeru, Oluwadamilola Temilade
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 75 - 75
  • [20] The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus
    Zeinab Tarhini
    Kamelia Manceur
    Julien Magne
    Muriel Mathonnet
    Jeremy Jost
    Niki Christou
    Scientific Reports, 12
12345